ArticleJAMA ophthalmology2023

Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.

Charles C Wykoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.